Results

Total Results: 1,640 records

Showing results for "therapy".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertensive-disorders-pregnancy-disposition-comments.pdf
    May 31, 2023 - Another reviewer proposed “Our knowledge about htn treatment for non pregnant and postpartum patient … In this scenario,92 patients would need to receive standard duration therapy to prevent one additional … studies have addressed differential outcomes between racial/ethnic groups in incidence, detection, treatment … Of the 103 women in each arm of the trial, no women in the treatment arm required hospital readmission … Regarding citation #1 (LactMed), we found no studies with a hydrochlorothiazide (HCTZ) treatment arm
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_disposition-comments.pdf
    July 10, 2012 - is not “treatment”. … The list of elements of brief intervention includes cognitive-behavioral therapy, which is a general … You have 3 types of therapy, 2 loci and methods of providing therapy (outpatient and residential), a … This section is focused on treatments for alcohol dependence. … : “It is possible that the assessments of alcohol misuse conducted in the included trials conceal therapeutic
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-analgesics-acute-pain-summary.pdf
    September 01, 2019 - Purpose of Review To evaluate effectiveness and harms of opioids compared to nonopioid analgesics as treatment … Key Messages • As initial therapy in the prehospital setting: – Nonsteroidal anti-inflammatory drugs … The use of ketamine for acute treatment of pain: a randomized, double-blind, placebo-controlled trial … Comparison of IV dexketoprofen trometamol, fentanyl, and paracetamol in the treatment of renal colic … Comparison of fentanyl and morphine in the prehospital treatment of ischemic type chest pain.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - trial or systematic review (or guidelines) including at least one new trial that characterized the treatment … A3 A superior new treatment: A pivotal trial or systematic review (or guidelines) whose results identified … another treatment as significantly superior to the one evaluated in the original review, based on efficacy … Important changes in effectiveness short of “opposing findings” A5 Clinically important expansion of treatment … to the conclusions involve refinement of original estimates or do the potential changes mean some therapies
  5. effectivehealthcare.ahrq.gov/products/systematic-review-updates/research
  6. effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research
  7. effectivehealthcare.ahrq.gov/products/mrsa-screening-2010/research-protocol
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - Risk factors that triggered screening included age, health status, therapeutic treatments, and recent … Colonized patients who subsequently developed neutropenic fever received empirical therapy with tigecycline … ] OR editorial[ti] OR letter[ti] OR news[ti] OR ((protocol[ti] AND (study[ti] OR trial[ti])) NOT ("therapy … protocol"[ti] OR "therapy protocols"[ti] OR "treatment protocol"[ti] OR "treatment protocols"[ti])) … difficile; or treatment in long- term care facility in previous 6 months • Statistically significant
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
    December 01, 2010 - Pharmacological treatment of dementia. … Acute stroke: evaluation and treatment. … Center EPC No No Year: 2005 3 4 Effectiveness of Antimicrobial Adjuncts to Scaling and Root- Planing Therapy … Narrative “Research and Clinical Implications” Year: July 2005 7 2 Diagnosis, Prognosis, and Therapy … 1 0 1 0 2 PAION Deutschland GmbH 0 0 2 0 2 Pfizer 0 0 2 0 2 Sanofi-Aventis 0 0 2 0 2 Transition Therapeutics
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-decision-models_methods.pdf
    July 01, 2012 - using different tests will have the same response to downstream treatments. … Although the downstream treatments may be the same in all test-and-treat strategies of interest, one … The evidence report also modeled hypothetical treatments with various effectiveness and safety profiles … Evidence exists to estimate the benefits and harms of pharmacologic therapy in those with and without … Specifically, the treatments for MCI in AD are at best only marginally effective,33 and it is unknown
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
    July 01, 2012 - Rapidly Evolving Tests A third challenge, especially relevant to medical tests, is that, even more than treatments … Time from results to treatment not reported. … diagnostic use Resources available to providers for diagnosis and treatment of condition vary … Treatment Trends As therapeutics arise that change the course of disease and modify outcomes, literature … ., people with arthritis, women, obese patients) or setting (e.g., primary care practice, physical therapy
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
    July 01, 2025 - moreover, adolescents who reported prescription stimulant misuse (and who had no history of stimulant therapyTreatment Episode Data Set (TEDS) 2022: Admissions to and Discharges from Substance Use Treatment Services … Per multivariate regression analysis, there was no significant effect of prescribed stimulant therapy … Adolescents who reported PSM with no history of stimulant therapy for ADHD at baseline had > 2.5 … Findings—Misuse Patterns Findings— Consequences Risk of Bias Data source: National Disease and Therapeutic
  13. effectivehealthcare.ahrq.gov/health-topics/stuttering
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
    November 01, 2013 - empirical evidence in order to minimize bias when representing the results of medical interventions and therapies … evidence syntheses depend on the published literature accurately representing what’s known about medical therapies … design and statistical approaches), types of participants (i.e., inclusion and exclusion criteria), treatments … For example, in a trial on the effect of hormone replacement therapy on cardiovascular events in recently … Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
    January 01, 2014 - However, the role of diet in the etiology and treatment of gout is a topic of considerable research … A set of draft key questions encompassing both diagnosis and treatment of gout were posted for public … relevant long-term outcomes (such as development of tophi, repeated flares that respond to urate lowering therapies … Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics … Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician
  16. effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
    October 01, 2011 - treatments? … This suggests a bias favoring rx therapy, in my view. … Section Comment Response Peer Reviewer #7 Results p 83 L-23 Naïve statement: that combination therapytreatments, especially for preschoolers and adolescents. … on the overall benefit/risk of rx treatments for ADHD.
  17. S38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
    October 01, 2007 - If education or evidence leads providers to conclude that 1 therapeutic approach is preferred over others … Thus, measures of agreement in treatments received by patients of different providers within a practice … Improving drug-therapy decisions through educa- tional outreach: a randomized controlled trial of academically … Explained variation in a model of therapeutic decision making is partitioned across patient, physician … A review of use of health care utilization databases for epidemiologic research on therapeutics.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - unresectable cases, however, a biopsy is taken and a formal stage is determined to guide the planning of treatments … that some Stage III cases are borderline resectable and may be appropriate targets for neoadjuvant therapy … adenocarcinoma is fatal if untreated, so it is critical to choose the right imaging test and initiate therapy … Were the study results unaffected by intervening treatments or disease progression/regression? … of patients receiving each specific ancillary treatment?
  19. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01.pdf
    May 01, 2005 - interventions for which the protocol explicitly allows for modification based on patient needs or concomitant treatments … Harms are defined as the “totality of possible adverse consequences of any intervention, therapy or … Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy … The Empirical Evidence of Bias in Trials Measuring Treatment Differences. … systematic review of combination long-acting beta-agonists and inhaled corticosteroids for maintenance therapy
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/assessing-the-risk-of-bias-in-systematic-reviews-of-health-care-interventions-01_0.pdf
    May 01, 2005 - interventions for which the protocol explicitly allows for modification based on patient needs or concomitant treatments … Harms are defined as the “totality of possible adverse consequences of any intervention, therapy or … Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy … The Empirical Evidence of Bias in Trials Measuring Treatment Differences. … systematic review of combination long-acting beta-agonists and inhaled corticosteroids for maintenance therapy

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: